ClinicalTrials.gg
CompletedNCT06540170Updated Aug 26, 2025Results posted

A Personalized Self-care Support Program for Primary Care Patients With Diabetic Foot Ulcer

An interventional study of A personalised self-care support program in Foot Ulcer, sponsored by National Healthcare Group Polyclinics. Completed at 1 site in Singapore. Open to participants aged 21 Years to 99 Years. Per ClinicalTrials.gov, last updated 2025-08-26.

Primary conditionDiabetic FootRegistry: Foot UlcerReclassifiedWhy we changed it
Registry
Foot Ulcer — the first condition term the registry derived for this study.
ClinicalTrials.gg
Diabetic Foot
Why
  1. The study's title name Diabetic Foot, a narrower term within Foot Ulcer.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by National Healthcare Group Polyclinics · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Not applicable
Ages
21 Years to 99 Years
Sex
All
01

Study summary

This clinical trial aims to learn if a personalized self-care program supporting self-care and Healing through Empowerment and Active Listening (HEALing), is acceptable to patients with diabetic foot ulcer (DFU) and wound care nurses, and is feasible to deliver supportive self-care for primary care patients living with DFU.

The main questions it aims to answer are:

  • Is the personalized self-care improvement program acceptable to patients with diabetic foot ulcer (DFU) and wound care nurses to deliver?
  • Is the personalized self-care improvement program feasible for supportive self-care for primary care patients living with DFU? Researchers will compare pre-intervention to post-intervention to see if the personalized self-care improvement program works to support self-care management for patients with DFU.

Participants will:

-receive three 30-minute face-to-face intervention sessions every 2 weeks within 6 weeks after their routine wound care dressing.

Read the detailed description

This study aims to assess the potential benefit(s) of a personalized intervention integrating motivational interviewing (MI) with positive psychological skills for supportive self-care among patients with diabetic foot ulcers.

A single-arm pilot feasibility study using a mixed-method approach will be conducted between Aug 2024 and February 2025. 30 participants will be recruited from nurse-led wound clinics in a large primary care sector and selected according to the inclusion criteria. Participants will receive three 30-minute face-to-face sessions of an MI-based personalized care program over 6 weeks to support DFU self-care coping behaviors.

The primary outcomes include the feasibility of recruitment and the acceptability of the proposed personalized intervention. Feasibility will be assessed based on recruitment and 4 weeks retention of participants from last intervention session through examination of screening logs and follow-up completion. Acceptability to patients and healthcare professionals (HCPs) will be evaluated using semi-structured individual interviews.

The secondary outcomes include patient-reported outcome measures (PROM) consisting of DFU self-care behaviors, self-efficacy, psychological determinants, and clinical endpoints such as foot skin conditions and glycemic control (measured by HbA1C). The results will be evaluated by comparing baseline and post-intervention data collected at week 0 and week 4 from last intervention session, for any differences in PROMs and clinical outcomes. Differences in PROMs between the two time points will be assessed using univariable analyses such as the chi-square test for categorical variables and independent samples t-test or analysis of variance (ANOVA) for continuous variables where appropriate.

Semi-structured face-to-face individual qualitative interviews will be conducted at the end of the pilot trial to provide insight into peoples' experiences of participation in the intervention. Data will be analyzed thematically.

02

Conditions studied

  • Foot Ulcer

Browse trials for

Keywords

  • Diabetic foot ulcer
  • self-care support
  • Motivational interviewing
03

In context

Diabetic Foot Reclassified

1,079 studies on the registry are indexed under Diabetic Foot; 221 are open to participants now.

This study's enrollment of 29 is below the median of 60 across 849 interventional studies indexed under Diabetic Foot.

Browse Diabetic Foot studies →

Lead sponsor

National Healthcare Group Polyclinics is the lead sponsor of 9 studies on the registry; 5 are open to participants now.

Compared within Diabetic Foot, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Foot Ulcer. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
21 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with diabetes and DFU aged 21 years or above receiving treatment and wound care at National Healthcare Group Polyclinics
  • HCPs, who are aged 21 years or above with a patient-facing role working in delivering program (only for qualitative interviews)

Exclusion criteria

Exclusion Criteria:

  • Patients have a diagnosis of critical lower limb ischemia, active osteomyelitis, Charcot foot, cognitive/psychiatric diagnoses, and hearing or vision impairment.
  • Pregnant women will be excluded from the study for both patient and HCP groups
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
29 participants (actual)

Study arms

  • Other
    Single arm

    Eligible and willing participants will be invited to participate in the program and receive three 30-minute face-to-face sessions (once every 2 weeks) within 6 weeks of enrolment.

    Behavioral: A personalised self-care support program

Interventions

  • BehavioralA personalised self-care support program

    A personalized care program consists of three 30-minute face-to-face sessions (once every 2 weeks) after patients' routine wound dressings to enhance self-efficacy, support emotional adjustments, and DFU self-care.

06

What researchers measure

Primary outcomes

  1. Feasibility of Recruiting and Retaining

    The number of patients recruited to the study and retained at the end of the study period will be documented.

    Time frame: 4 weeks post-intervention from baseline.

  2. Acceptability of the Intervention

    Participants will be interviewed to determine the acceptability of the intervention.

    Time frame: 4 weeks post-intervention from baseline.

Secondary outcomes

  1. Patients' Adherence to Foot Self-care Behaviour

    Measured using the 7-item Diabetes Foot Self-Care Behavior Scale. All items on the scale are rated on a 5-point Likert-type scale. The higher scores represent better foot self-care behaviors. The minimum value is 7 and the maximum is 35.

    Time frame: 4 weeks post-intervention from baseline.

  2. Patients' Foot Care Confidence (Self-efficacy)

    Measured using the 12-item Foot Care Confidence Scale. All items on the scale are rated on a 5-point Likert-type scale. The higher scores represent better foot care confidence. The minimum value is 12 and the maximum value is 60.

    Time frame: 4 weeks post-intervention from baseline.

  3. Patients' Illness Belief

    Measured using the 8-item Brief Illness Perception Questionnaire, each item is rated on a 0-10 scale, with higher scores indicating a more threatening perception of the illness. The total score is calculated by summing the scores of all eight items where items 3, 4, and 7 are inversed. The possible range of scores is 0 (minimum value)-80 (maximum value). Higher scores indicate worse illness perception.

    Time frame: 4 weeks post-intervention from baseline.

  4. Patients' Perceptions of Autonomy Support

    Measured using the 6-item Health Care Climate Questionnaire that patients rate items on a 7-point Likert scale (1 = not at all true, 7 = very true). The minimum value is 1 and the maximum value is 7. The higher score represents greater autonomy support.

    Time frame: 4 weeks post-intervention from baseline.

  5. Patients' Diabetes Distress

    Measured using Diabetes Distress Scale consists of 17 items with four subscales including emotional burden, physician-related distress, regimen-related distress, and interpersonal distress. All items were rated on a 6-point Likert scale. The minimum value is 1 and the maximum value is 6. The higher score indicates greater distress.

    Time frame: 4 weeks post-intervention from baseline.

  6. Patients' Knowledge of Recognizing Wound Deterioration

    Measured using Warning Signs of Diabetic Foot Ulcer Deterioration Questionnaire comprising of 12 items. Each item with the correct answer obtains a score of 1. The minimum score is 0 and the maximum value is 12. The higher scores represent better knowledge.

    Time frame: 4 weeks post-intervention from baseline.

  7. Patients' Quality of Life

    Measured using EQ-5D-5L that is self-reported by patients and consists of two parts: a descriptive system and a visual analogue scale. The visual analogue scale for imaginative health state is used for the pilot study. The minimum value is 0 and the maximum value is 100. The higher score represents the better 0 imaginative health state.

    Time frame: 4 weeks post-intervention from baseline.

  8. HbA1c

    HbA1c for participants who have completed the program.

    Time frame: 4 weeks post-intervention from baseline.

07

Results

Posted Aug 26, 2025

Participant flow

Participant flow — Overall Study
MilestoneSingle Arm Study
Started29
Completed26
Not completed3

Outcome measures

PrimaryFeasibility of Recruiting and Retaining

The number of patients recruited to the study and retained at the end of the study period will be documented.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Count of participants · Participants
Feasibility of Recruiting and Retaining
ParticipantsSingle Arm
Feasibility of Recruiting and Retaining26
PrimaryAcceptability of the Intervention

Participants will be interviewed to determine the acceptability of the intervention.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Count of participants · Participants
Acceptability of the Intervention
ParticipantsSingle Arm Study
Acceptability of the Intervention26
SecondaryPatients' Adherence to Foot Self-care Behaviour

Measured using the 7-item Diabetes Foot Self-Care Behavior Scale. All items on the scale are rated on a 5-point Likert-type scale. The higher scores represent better foot self-care behaviors. The minimum value is 7 and the maximum is 35.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Mean · score on a scale
Patients' Adherence to Foot Self-care Behaviour
score on a scaleSingle Arm Study
Patients' Adherence to Foot Self-care Behaviour20.2 ± 3.8
SecondaryPatients' Foot Care Confidence (Self-efficacy)

Measured using the 12-item Foot Care Confidence Scale. All items on the scale are rated on a 5-point Likert-type scale. The higher scores represent better foot care confidence. The minimum value is 12 and the maximum value is 60.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Mean · score on a scale
Patients' Foot Care Confidence (Self-efficacy)
score on a scaleSingle Arm Study
Patients' Foot Care Confidence (Self-efficacy)32.7 ± 4.3
SecondaryPatients' Illness Belief

Measured using the 8-item Brief Illness Perception Questionnaire, each item is rated on a 0-10 scale, with higher scores indicating a more threatening perception of the illness. The total score is calculated by summing the scores of all eight items where items 3, 4, and 7 are inversed. The possible range of scores is 0 (minimum value)-80 (maximum value). Higher scores indicate worse illness perception.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Mean · score on a scale
Patients' Illness Belief
score on a scaleSingle Arm
Patients' Illness Belief47.9 ± 10
SecondaryPatients' Perceptions of Autonomy Support

Measured using the 6-item Health Care Climate Questionnaire that patients rate items on a 7-point Likert scale (1 = not at all true, 7 = very true). The minimum value is 1 and the maximum value is 7. The higher score represents greater autonomy support.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Mean · score on a scale
Patients' Perceptions of Autonomy Support
score on a scaleSingle Arm Study
Patients' Perceptions of Autonomy Support3.5 ± 0.9
SecondaryPatients' Diabetes Distress

Measured using Diabetes Distress Scale consists of 17 items with four subscales including emotional burden, physician-related distress, regimen-related distress, and interpersonal distress. All items were rated on a 6-point Likert scale. The minimum value is 1 and the maximum value is 6. The higher score indicates greater distress.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Mean · score on a scale
Patients' Diabetes Distress
score on a scaleSingle Arm Study
Patients' Diabetes Distress3.5 ± 0.9
SecondaryPatients' Knowledge of Recognizing Wound Deterioration

Measured using Warning Signs of Diabetic Foot Ulcer Deterioration Questionnaire comprising of 12 items. Each item with the correct answer obtains a score of 1. The minimum score is 0 and the maximum value is 12. The higher scores represent better knowledge.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Mean · score on a scale
Patients' Knowledge of Recognizing Wound Deterioration
score on a scaleSingle Arm Study
Patients' Knowledge of Recognizing Wound Deterioration7.7 ± 2.0
SecondaryPatients' Quality of Life

Measured using EQ-5D-5L that is self-reported by patients and consists of two parts: a descriptive system and a visual analogue scale. The visual analogue scale for imaginative health state is used for the pilot study. The minimum value is 0 and the maximum value is 100. The higher score represents the better 0 imaginative health state.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Mean · units on a scale
Patients' Quality of Life
units on a scaleSingle Arm Study
Patients' Quality of Life57.3 ± 15.2
SecondaryHbA1c

HbA1c for participants who have completed the program.

Time frame:
4 weeks post-intervention from baseline.
Reported as:
Mean · mmol/mol
HbA1c
mmol/molSingle Arm Study
HbA1c83 ± 42

Adverse events

Collected over All-Cause Mortality, Serious, and Other [Not Including Serious] Adverse Events were not monitored/assessed (as this is a self-care education intervention with no risk of adverse event). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Single Arm Study———

Baseline characteristics

Patients with diabetic foot ulcers receiving wound care at the participating clinics

Age, Continuous
Age, Continuous(years)Single Arm Study
Mean64 ± 10
Sex: Female, Male
Sex: Female, Male(Participants)Single Arm Study
Female8
Male18
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Single Arm Study
American Indian or Alaska Native0
Asian26
Native Hawaiian or Other Pacific Islander0
Black or African American0
White0
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Single Arm Study
Singapore26
08

Study locations

1 site
  • National Healthcare Group Polyclinics
    Singapore, Singapore
09

References and documents

Publications

  • Zhu X, Lee ES, Chan FHF, Yin R, Lim PXH, Koh RWS, Judith C, Wei L, Li S, Phrommarad P, Chin GHY, Lim VH, Low RSY, Chen YC, Griva K. Feasibility and acceptability of a personalised self-care support programme for primary care patients with diabetic foot ulcers delivered by wound care nurses: the HEALing study protocol. BMJ Open. 2025 Oct 7;15(10):e098024. doi: 10.1136/bmjopen-2024-098024. PubMed 41062140 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2024 to primary completion in Jan 2025, 4 months.

Results were first posted in Aug 2025, 7 months after primary completion.

Of 243 non-industry interventional studies with no phase under Diabetic Foot, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's 4 months is below that.

Counting every sponsor, half of 347 studies reached it within 22 months; a quarter within 9 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 27, 2024
First posted
Aug 6, 2024
StartActual
Aug 13, 2024
Primary completionActual
Jan 11, 2025
CompletionActual
Jan 11, 2025
Results first posted
Aug 26, 2025
Last update
Aug 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06540170
Lead sponsor
National Healthcare Group Polyclinics
Collaborators
Nanyang Technological University
Responsible party
Julia Zhu Xiaoli (Senior Nurse Clinician Wound Management, National Healthcare Group Polyclinics) — Principal investigator
First posted
Aug 6, 2024
Start date
Aug 13, 2024
Primary completion
Jan 11, 2025
Completion
Jan 11, 2025
Results posted
Aug 26, 2025
Last update
Aug 26, 2025

Study contacts

Julia Xiaoli Zhu
principal investigator · National Healthcare Group Polyclinics Singapore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion